Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

N
070
NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis

Favorite
127
National trends in utilization of glucose lowering medications by older people with diabetes in long-term care facilities, 2009 to 2019

Favorite
BSPOT33
Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®

Favorite
335
Natural history of knee osteoarthritis with regards to other joint sites and knee replacement: a population-based cohort study in the UK Clinical Practice Research Datalink (CPRD)

Favorite
281
Neonatal Intensive Care Unit Services among Commercially Insured Infants in the United States, 2016 – 2023

Favorite
128
Network Analysis of Chronic Medication Use in Older Adults Living with Dementia Prior to and Following Diagnosis: A Web-based Visualisation Tool

Favorite
023
Neutropenia among patients with prostate cancer: Analysis of four US real world databases

Favorite
114
New Medication Use in Post-Acute Sequelae Of COVID-19 (PASC): An EHR-based Study From the RECOVER Program

Favorite
115
Nirmatrelvir and Ritonavir (Paxlovid) Prognostication: Unveiling Utilization Trends with Neural Network Time Series Forecasting

Favorite
116
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe Covid-19: An Analysis of the National Covid Cohort Collaborative (N3C)

Favorite
CSPOT50
No Elevated Risk of Cataract in Amiodarone Users: A Population-based Active-Comparator Study

Favorite
056
Non-Alcoholic Steatohepatitis (NASH) as a Risk Factor in Hepatocellular Carcinoma (HCC) Development

Favorite
346
Novel Adverse Event of Atezolizumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database

Favorite
059
Novel Glucose-lowering Drugs and Incident Dementia Among Patients With Type 2 Diabetes and Comorbid Mental Disorders: A Population-based Cohort Study

Favorite
293
Nurses’ intention to report adverse drug events, a survey using the theory of planned behavior.

Favorite